AF
SRDX

Amalgamated Financial’s Surmodics SRDX Stock Holding History

Amalgamated Financial’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$304K Buy
+6,708
New +$294K ﹤0.01% 1731

Other funds holding SRDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Amalgamated Financial's SRDX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Surmodics (SRDX) in Q1 2022: 6,708 shares worth $304K. The stake represents ﹤0.01% of the portfolio and ranks #1731 among its holdings.

135 funds tracked by Wall St. Rank hold SRDX as of Q1 2022.

  • Amalgamated Financial held 6,708 shares of Surmodics worth $304K as of Q1 2022.
  • Surmodics was a new Amalgamated Financial position in Q1 2022.
  • Surmodics made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1731 holding.
  • 135 funds tracked by Wall St. Rank held Surmodics as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.